Inogen Inc. logo

Inogen Inc. (6IO)

Market Closed
3 Dec, 20:32
XSTU XSTU
5. 85
+0.1
+1.74%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-3.4 Eps
5.75
Previous Close
Day Range
5.85 5.85
Year Range
5.05 11.9
Want to track 6IO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 81 days

Summary

6IO closed Wednesday higher at €5.85, an increase of 1.74% from Tuesday's close, completing a monthly decrease of -17.02% or €1.2. Over the past 12 months, 6IO stock lost -33.14%.
6IO is not paying dividends to its shareholders.
The last earnings report, released on Nov 05, 2025, exceeded the consensus estimates by 0.09%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports. The next scheduled earnings report is due on Feb 24, 2026.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

6IO Chart

Here's Why You Should Add Inogen Stock to Your Portfolio Now

Here's Why You Should Add Inogen Stock to Your Portfolio Now

INGN gains momentum from rising POC demand, new product launches and strong Q3 sales, even as competition and forex swings temper near-term growth.

Zacks | 7 hours ago
Down 19.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Inogen (INGN)

Down 19.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Inogen (INGN)

Inogen (INGN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks | 3 weeks ago
Slow Progress At Inogen

Slow Progress At Inogen

Inogen (INGN) continues its turnaround, showing progress in revenue growth and margins, but the pace remains slower and riskier than the market desires. INGN posted positive adjusted EBITDA and raised full-year guidance, despite mixed quarterly results and ongoing volatility in direct-to-consumer and rental segments. The company's strong market position, new product launches, and partnerships offer long-term growth potential, especially as patients consistently prefer portable solutions.

Seekingalpha | 3 weeks ago

Inogen Inc. (6IO) FAQ

What is the stock price today?

The current price is €5.85.

On which exchange is it traded?

Inogen Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is 6IO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 24, 2026.

Has Inogen Inc. ever had a stock split?

No, there has never been a stock split.

Inogen Inc. Profile

- Industry
- Sector
Kevin R. M. Smith CEO
XSTU Exchange
US45780L1044 ISIN
US Country
766 Employees
- Last Dividend
- Last Split
14 Feb 2014 IPO Date

Overview

Inogen, Inc. is a leading medical technology company that focuses on the development, manufacturing, and commercialization of portable oxygen concentrators. These devices are essential for patients who require supplemental long-term oxygen therapy, catering to those suffering from chronic respiratory conditions. The company's mission is to improve the quality of life for its users by offering innovative solutions that promote mobility and independence. Inogen has established a strong market presence both in the United States and internationally, serving patients, physicians, other clinicians, and third-party payors. Founded in 2001, Inogen has its headquarters in Goleta, California, from where it continues to expand its reach and impact in the medical technology space.

Products and Services

  • Inogen One: This is Inogen's flagship portable oxygen concentrator, designed to enhance the mobility of patients while providing a reliable source of supplemental oxygen. By concentrating the air around the patient, the Inogen One device ensures that users have a continuous oxygen supply, supporting their respiratory needs without compromising their lifestyle.
  • Inogen At Home: Recognizing the need for a stationary solution for home use, Inogen also offers the Inogen At Home oxygen concentrator. This device is engineered for efficiency and convenience, providing high-quality oxygen therapy with minimal noise and power usage, making it an ideal companion for patients at home.
  • Simeox: Simeox is a technologically advanced airway clearance device offered by Inogen. It aims to assist patients with mucus clearance, enhancing their pulmonary function. This device is especially useful for individuals with conditions that lead to increased mucus production, facilitating easier breathing.
  • Batteries and Accessories: In addition to the main oxygen concentrator units, Inogen provides a range of batteries and accessories to support and enhance the functionality of its products. This includes batteries for extended mobility, carrying cases, and other accessories designed to improve the user experience.
  • Rental Services: Understanding that purchasing might not be the best option for all, Inogen offers rental services for its products. This allows patients to access the benefits of Inogen's oxygen concentrators without the upfront cost, providing flexibility and ease of use.

Contact Information

Address: 301 Coromar Drive
Phone: 805 562 0500